Omega Healthcare Q1 net income and adjusted FFO rise

Omega Healthcare Investors,

28/04/2026 21:24

Overview

U.S. healthcare REIT's Q1 net income and adjusted FFO rose yr/yr

Company completed $251 mln in new investments during Q1

Raised full-year adjusted FFO guidance midpoint; expects $480 mln asset sale in Q2

Outlook

Omega raises 2026 Adjusted FFO guidance midpoint to $3.22 per diluted share

Company expects sale of 18 CommuniCare facilities in Q2 for $480 mln

Omega says operating metrics remain strong, investment pipeline remains active

Result Drivers

NEW INVESTMENTS - Q1 results benefited from $251 mln in new investments, including real estate acquisitions, loan fundings, and equity stakes in unconsolidated entities

PORTFOLIO MANAGEMENT - Company cited active portfolio management as a driver of improved FAD per share and overall results, per CEO Taylor Pickett

OPERATOR PERFORMANCE - Continued rent payments from key operators, including Genesis and Maplewood, supported rental income and results

Company press release: ID:nBw7WVt08a

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 EPS
$0.47
Q1 Net Income
$159 mln
Q1 Adjusted FFO
$260 mln


Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 7 "strong buy" or "buy", 10 "hold" and 1 "sell" or "strong sell"

The average consensus recommendation for the specialized reits peer group is "buy."

Wall Street's median 12-month price target for Omega Healthcare Investors, Inc is $48.00, about 2.8% above its April 27 closing price of $46.67

The stock recently traded at 24 times the next 12-month earnings vs. a P/E of 24 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)